| Literature DB >> 28105152 |
Aurélie Gomes1, Adrien Russo1, Guillaume Vidal2, Elise Demange2, Pauline Pannetier2, Zied Souguir2, Jean-Michel Lagarde3, Bernard Ducommun4, Valérie Lobjois1.
Abstract
Pharmacological evaluation of anticancer drugs using 3D in vitro models provides invaluable information for predicting in vivo activity. Artificial matrices are currently available that scale up and increase the power of such 3D models. The aim of the present study was to propose an efficient and robust imaging and analysis pipeline to assess with quantitative parameters the efficacy of a particular cytotoxic drug. HCT116 colorectal adenocarcinoma tumor cell multispheres were grown in a 3D physiological hyaluronic acid matrix. 3D microscopy was performed with structured illumination, whereas image processing and feature extraction were performed with custom analysis tools. This procedure makes it possible to automatically detect spheres in a large volume of matrix in 96-well plates. It was used to evaluate drug efficacy in HCT116 spheres treated with different concentrations of topotecan, a DNA topoisomerase inhibitor. Following automatic detection and quantification, changes in cluster size distribution with a topotecan concentration-dependent increase of small clusters according to drug cytotoxicity were observed. Quantitative image analysis is thus an effective means to evaluate and quantify the cytotoxic and cytostatic activities of anticancer drugs on 3D multicellular models grown in a physiological matrix.Entities:
Keywords: 3D matrix; 3D models; automatic image quantification; microscopy; preclinical drug evaluation
Year: 2016 PMID: 28105152 PMCID: PMC5228506 DOI: 10.3892/ol.2016.5221
Source DB: PubMed Journal: Oncol Lett ISSN: 1792-1074 Impact factor: 2.967
Figure 1.The quantitative image analysis procedure. Cells were cultured in Biomimesys® 3D matrix in a 96-well format. In each well, cells grew as clusters of various sizes. The bright field microscopy image presents the diversity of the size of clusters detected in the matrix 6 days after seeding HCT116 cells (Scale bar, 100 µm). Imaging with a wide-field ApoTome microscope allowed z-stack collection from 9 overlapping fields of view. Stitching together their maximal projections reconstructed the majority of each well. A segmentation, quantification and classification procedure was used to determine cluster size distribution in various experimental conditions, thus allowing drug evaluation with IC50 determination according to morphometric parameters.
Figure 2.Image z-stack stitching to reconstruct complete well information. A total of 9 image tiles per well were acquired by fluorescence microscopy. (A) Stitching was performed using matching overlaps to reconstruct a global z-stack image of each microwell. (B) Global view of the microwell plate with stitched images for each position.
Figure 3.Image processing and feature extraction. A schematic representation of the image processing and feature extraction pipeline.
Figure 4.Procedure application to the study the effect of topotecan on HCT116 colorectal carcinoma cells grown in a 3D Biomimesys® matrix. Cells were seeded in 3D matrices and imaging was performed at day 9 (i.e. following 3 days of treatment). (A) Global view of microwells following the stitching together of the 9 image tiles for the indicated concentrations of topotecan. (B) Size distribution of cell clusters at increasing concentrations of topotecan. For each concentration, box-and-whisker plots present the median, the quartile and range of each data set. Each plot corresponds to the analysis of the size of clusters from 4–6 wells per concentration. (C) Representation of cluster size by class. The percentage of clusters in each area class (in A.U) was calculated from the total number of clusters from 4–6 wells per concentration. A.U., arbitrary units.